Author:
Kaur Navjyot,Pruthvi CR,Rohit Manojkumar
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Levy WC (2017) Should nonischemic CRT candidates receive CRT-P or CRT-D? J Am Coll Cardiol 69(13):1679–1682
2. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, PARADIGM-HF Investigators and Committees et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004
3. Tung R, Zimetbaum P, Josephson ME (2008) A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 52(14):1111–1121
4. Carlos de D, Gonzalez-Torres L, Jose Maria N et al (2018) Advances in pharmacological therapy in reduced left ventricular heart failure patients with implantable cardiac defibrillator and cardiac resynchronization. Clin Cardiol J 2(1):1–5
5. Golwala H, Bajaj NS, Arora G, Arora P (2017) Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis. Circulation 135(2):201–203. https://doi.org/10.1161/CIRCULATIONAHA.116.026056 Epub 2016 Dec 19. PMID: 27993908; PMCID: PMC5416382
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献